Trendy Stocks
How Did The Lipocine (LPCN) Stock Rise In The Extended Trading?
In after-hours trading on Monday, Lipocine Inc. (NASDAQ: LPCN) rose 10.60% to $0.48 on no relevant news. LPCN stock lost -4.62% to finish the trading
Tag: LPCN stock
Stocks to Invest
Lipocine, Inc. (LPCN) Stock Sinking in the Aftermarket, Here’s What you Should Know.
Lipocine, Inc. (LPCN) is an innovative clinical-stage biotherapeutics firm engaged in drug production for metabolic and endocrine disorders. The lead product candidates of the company
Market Insights
Lipocine Inc. (LPCN) Stock on the Rise Following Exclusive Licensing Agreement with Antares Pharma
Lipocine Inc. (LPCN) stock prices were up by 8,8496% around the time market trading commenced on October 18th 2021. This brought the price per share
